Regeneron Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of pharmaceutical products to treat human disorders and conditions. It conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, and cardiovascular diseases. The company’s clinical development programs include VEGF Trap for oncology, VEGF Trap for eye diseases, and Interleukin-1 (IL-1) Trap for inflammatory diseases. The VEGF Trap is a protein-based product candidate designed to bind Vascular Endothelial Growth Factor (VEGF)...